- Home
- FTFT vs CNSP Comparison
FTFT vs CNSP Comparison
Compare FTFT & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- CNSP
- Stock Information
- Founded
- FTFT N/A
- CNSP 2017
- Country
- FTFT United States
- CNSP United States
- Employees
- FTFT N/A
- CNSP N/A
- Industry
- FTFT Business Services
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- FTFT Consumer Discretionary
- CNSP Health Care
- Exchange
- FTFT Nasdaq
- CNSP Nasdaq
- Market Cap
- FTFT 6.2M
- CNSP 6.5M
- IPO Year
- FTFT N/A
- CNSP 2019
- Fundamental
- Price
- FTFT $0.19
- CNSP $2.71
- Analyst Decision
- FTFT
- CNSP Strong Buy
- Analyst Count
- FTFT 0
- CNSP 1
- Target Price
- FTFT N/A
- CNSP $25.00
- AVG Volume (30 Days)
- FTFT 11.9M
- CNSP 1.0M
- Earning Date
- FTFT 04-15-2025
- CNSP 03-31-2025
- Dividend Yield
- FTFT N/A
- CNSP N/A
- EPS Growth
- FTFT N/A
- CNSP N/A
- EPS
- FTFT N/A
- CNSP N/A
- Revenue
- FTFT $18,543,659.00
- CNSP N/A
- Revenue This Year
- FTFT N/A
- CNSP N/A
- Revenue Next Year
- FTFT N/A
- CNSP N/A
- P/E Ratio
- FTFT N/A
- CNSP N/A
- Revenue Growth
- FTFT N/A
- CNSP N/A
- 52 Week Low
- FTFT $0.18
- CNSP $2.00
- 52 Week High
- FTFT $1.21
- CNSP $1,100.00
- Technical
- Relative Strength Index (RSI)
- FTFT 34.34
- CNSP 39.44
- Support Level
- FTFT $0.20
- CNSP $2.38
- Resistance Level
- FTFT $0.25
- CNSP $3.03
- Average True Range (ATR)
- FTFT 0.04
- CNSP 0.33
- MACD
- FTFT -0.00
- CNSP 0.04
- Stochastic Oscillator
- FTFT 1.23
- CNSP 55.47
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.